Moore JO - Search Results

1

Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia.

Lanasa MC, Davis PH, Datto M, Li Z, Gockerman JP, Moore JO, DeCastro CM, Friedman DR, Diehl LF, Rehder C, Cook H, Daugherty FJ, Matta KM, Weinberg JB, Rizzieri D. Lanasa MC, et al. Among authors: moore jo. Leuk Lymphoma. 2012 Feb;53(2):218-24. doi: 10.3109/10428194.2011.610012. Epub 2011 Sep 23. Leuk Lymphoma. 2012. PMID: 21827374

2

Phase I study of temozolomide and laromustine (VNP40101M) in patients with relapsed or refractory leukemia.

Rizzieri D, LoRusso S, Tse W, Khan K, Advani A, Moore J, Karsten V, Cahill A, Gerson SL. Rizzieri D, et al. Clin Lymphoma Myeloma Leuk. 2010 Jun;10(3):211-6. doi: 10.3816/CLML.2010.n.033. Clin Lymphoma Myeloma Leuk. 2010. PMID: 20511167 Clinical Trial.

3

Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.

Heyman B, Rizzieri D, Adams DJ, De Castro C, Diehl L, Li Z, Moore J, Beaven A. Heyman B, et al. Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):679-686. doi: 10.1016/j.clml.2018.07.285. Epub 2018 Jul 29. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30166257 Clinical Trial.

4

Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia.

McCune SL, Gockerman JP, Moore JO, Decastro CM, Bass AJ, Chao NJ, Long GD, Vredenburgh JJ, Gasparetto C, Adams D, Payne N, Rizzieri DA. McCune SL, et al. Among authors: moore jo. Leuk Lymphoma. 2002 May;43(5):1007-11. doi: 10.1080/10428190290021597. Leuk Lymphoma. 2002. PMID: 12148879

5

Rituximab in lymphocyte predominance Hodgkin's disease: a case series.

Ibom VK, Prosnitz RG, Gong JZ, Moore JO, DeCastro CM, Prosnitz LR, Rizzieri DA, Gockerman JP. Ibom VK, et al. Among authors: moore jo. Clin Lymphoma. 2003 Sep;4(2):115-8. doi: 10.3816/clm.2003.n.021. Clin Lymphoma. 2003. PMID: 14556684

6

Dose-intense cyclophosphamide and etoposide for patients with refractory or high-risk non-Hodgkin's lymphoma.

Talbot J, Ibom VK, Rizzieri DA, Barrier R, Niedzwieki D, DeCastro CM, Moore JO, Buckley P, Laney R, Stevenson D, Rumbaugh H, Gockerman JP. Talbot J, et al. Among authors: moore jo. Clin Lymphoma. 2004 Sep;5(2):116-22. doi: 10.3816/clm.2004.n.018. Clin Lymphoma. 2004. PMID: 15453927

7

Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels.

Levesque MC, Chen Y, Beasley BE, O'Loughlin CW, Gockerman JP, Moore JO, Weinberg JB. Levesque MC, et al. Among authors: moore jo. Leuk Res. 2006 Jan;30(1):24-8. doi: 10.1016/j.leukres.2005.05.022. Epub 2005 Jul 21. Leuk Res. 2006. PMID: 16039714

8

Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia.

Weinberg JB, Volkheimer AD, Chen Y, Beasley BE, Jiang N, Lanasa MC, Friedman D, Vaccaro G, Rehder CW, Decastro CM, Rizzieri DA, Diehl LF, Gockerman JP, Moore JO, Goodman BK, Levesque MC. Weinberg JB, et al. Among authors: moore jo. Am J Hematol. 2007 Dec;82(12):1063-70. doi: 10.1002/ajh.20987. Am J Hematol. 2007. PMID: 17654680 Free article.

9

Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia.

Rao AV, Younis IR, Sand GJ, Spasojevic I, Adams DJ, Decastro CM, Gockerman JP, Peterson BL, Petros WP, Moore JO, Rizzieri DA. Rao AV, et al. Among authors: moore jo. Leuk Lymphoma. 2008 Aug;49(8):1523-9. doi: 10.1080/10428190802210700. Leuk Lymphoma. 2008. PMID: 18766965 Clinical Trial.

10

A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia.

Friedman DR, Weinberg JB, Barry WT, Goodman BK, Volkheimer AD, Bond KM, Chen Y, Jiang N, Moore JO, Gockerman JP, Diehl LF, Decastro CM, Potti A, Nevins JR. Friedman DR, et al. Among authors: moore jo. Clin Cancer Res. 2009 Nov 15;15(22):6947-55. doi: 10.1158/1078-0432.CCR-09-1132. Epub 2009 Oct 27. Clin Cancer Res. 2009. PMID: 19861443 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

221 results

Search Page